HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masayuki Yamamoto Selected Research

Basic-Leucine Zipper Transcription Factors

1/2021Transcription Factor MAFF (MAF Basic Leucine Zipper Transcription Factor F) Regulates an Atherosclerosis Relevant Network Connecting Inflammation and Cholesterol Metabolism.
7/2015Compound mouse mutants of bZIP transcription factors Mafg and Mafk reveal a regulatory network of non-crystallin genes associated with cataract.
10/2010Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene.
12/2006Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2.
4/2006Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masayuki Yamamoto Research Topics

Disease

62Neoplasms (Cancer)
03/2022 - 05/2002
51Inflammation (Inflammations)
06/2022 - 01/2004
28Hypoxia (Hypoxemia)
01/2022 - 02/2002
26Anemia
01/2022 - 05/2003
24Carcinogenesis
01/2022 - 02/2002
14Fibrosis (Cirrhosis)
02/2021 - 08/2004
12Lung Injury
10/2020 - 02/2002
10Obesity
10/2021 - 10/2009
10Hyperoxia
11/2020 - 02/2002
10Starvation
01/2020 - 02/2007
9Pneumonia (Pneumonitis)
12/2019 - 11/2004
9Neoplasm Metastasis (Metastasis)
11/2016 - 04/2002
8Sickle Cell Anemia (Hemoglobin S Disease)
03/2022 - 07/2002
8Necrosis
01/2021 - 03/2006
8Atherosclerosis
01/2021 - 03/2004
7Body Weight (Weight, Body)
12/2020 - 01/2007
7Insulin Resistance
01/2020 - 02/2008
7Ischemia
01/2020 - 12/2007
7Acute Lung Injury
11/2009 - 06/2005
6Wounds and Injuries (Trauma)
01/2022 - 02/2003
6Hypertension (High Blood Pressure)
01/2022 - 12/2005
6Asthma (Bronchial Asthma)
11/2021 - 07/2005
6Reperfusion Injury
01/2017 - 08/2009
5Type 2 Diabetes Mellitus (MODY)
01/2022 - 04/2015
5Hepatocellular Carcinoma (Hepatoma)
01/2022 - 05/2002
5Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 05/2003
5Lung Neoplasms (Lung Cancer)
02/2021 - 03/2006
5Kidney Diseases (Kidney Disease)
12/2020 - 04/2011
5Chronic Renal Insufficiency
08/2020 - 04/2014
5Proteinuria
11/2019 - 10/2003
5Hypersensitivity (Allergy)
10/2019 - 07/2005
5Leukemia
01/2017 - 05/2007
5Fatty Liver
02/2016 - 02/2010
5Lung Diseases (Lung Disease)
02/2016 - 02/2009
5Liver Diseases (Liver Disease)
06/2015 - 05/2007
5Carcinoma (Carcinomatosis)
11/2014 - 09/2004
5Breast Neoplasms (Breast Cancer)
04/2014 - 02/2002
5Emphysema
01/2009 - 11/2004
4Gallbladder Neoplasms (Gallbladder Cancer)
12/2019 - 05/2003
4Hyperplasia
01/2016 - 07/2005
4Stomach Neoplasms (Stomach Cancer)
11/2015 - 11/2002
4Atrophy
03/2014 - 07/2004
4Chronic Obstructive Pulmonary Disease (COPD)
08/2013 - 11/2004
3Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

45Transcription Factors (Transcription Factor)IBA
01/2022 - 02/2002
43Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2002
40AntioxidantsIBA
11/2020 - 02/2002
29EnzymesIBA
01/2020 - 02/2002
26ErythropoietinFDA Link
01/2022 - 05/2002
19Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 09/2002
17CytokinesIBA
03/2022 - 05/2003
14Messenger RNA (mRNA)IBA
01/2021 - 02/2002
12Pharmaceutical PreparationsIBA
01/2022 - 02/2008
11DNA (Deoxyribonucleic Acid)IBA
01/2021 - 02/2002
10NF-E2-Related Factor 2IBA
01/2016 - 07/2007
9Oxygen (Dioxygen)IBA
12/2021 - 02/2002
8Biomarkers (Surrogate Marker)IBA
11/2021 - 04/2009
8GlobinsIBA
11/2021 - 07/2002
8Glucose (Dextrose)FDA LinkGeneric
01/2020 - 06/2005
8sulforaphaneIBA
01/2019 - 09/2003
8Oxidants (Oxidizing Agents)IBA
01/2019 - 09/2002
8SmokeIBA
12/2018 - 11/2004
8Glutathione (Reduced Glutathione)IBA
01/2017 - 02/2002
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2010 - 07/2002
71- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA
01/2019 - 01/2007
7IronIBA
11/2018 - 07/2004
6NitrogenIBA
12/2020 - 02/2007
6TriterpenesIBA
01/2013 - 01/2007
6Paclitaxel (Taxol)FDA LinkGeneric
12/2006 - 02/2002
5LipidsIBA
12/2021 - 01/2009
5Biological ProductsIBA
12/2021 - 11/2010
5CarcinogensIBA
01/2021 - 09/2002
5Heme Oxygenase-1IBA
01/2021 - 02/2002
5Basic-Leucine Zipper Transcription FactorsIBA
01/2021 - 04/2006
5Blood Glucose (Blood Sugar)IBA
01/2020 - 08/2013
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 02/2018
4Urethane (Ethyl Carbamate)IBA
01/2022 - 01/2011
4Interleukin-1beta (Interleukin 1 beta)IBA
01/2021 - 09/2003
4Triglycerides (Triacylglycerol)IBA
12/2020 - 02/2003
48-Hydroxy-2'-DeoxyguanosineIBA
02/2020 - 11/2004
4Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2020 - 03/2014
4Kelch-Like ECH-Associated Protein 1IBA
01/2020 - 01/2016
4GATA Transcription FactorsIBA
08/2019 - 05/2007
4Heme (Haem)IBA
01/2019 - 06/2006
4Bleomycin (Blenoxane)FDA LinkGeneric
03/2017 - 08/2004
4Insulin (Novolin)FDA Link
01/2017 - 08/2014
4Uridine Diphosphate (UDP)IBA
01/2017 - 02/2002
4XenobioticsIBA
01/2016 - 02/2007
4Interleukin-6 (Interleukin 6)IBA
10/2015 - 07/2002
4Phosphotransferases (Kinase)IBA
01/2015 - 06/2003
4Fluorouracil (Carac)FDA LinkGeneric
11/2014 - 11/2002
4Cisplatin (Platino)FDA LinkGeneric
08/2009 - 11/2002
3Rosiglitazone (Avandia)FDA Link
06/2022 - 12/2020
3halofuginoneIBA
01/2022 - 01/2017
3Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2021 - 07/2003

Therapy/Procedure

28Therapeutics
02/2021 - 02/2002
10Drug Therapy (Chemotherapy)
01/2022 - 10/2003
5Chemoprevention
01/2016 - 09/2002
4Lymph Node Excision (Lymph Node Dissection)
12/2019 - 11/2015
4Oral Administration
01/2013 - 12/2004